The BANK of Greenland's Annual Report 2023

Udgivet den 27-02-2024  |  kl. 14:17  |  

Increase in business volume and record result

The BANK of Greenland achieved a profit before tax of DKK 244.6 million in 2023, compared to DKK 109.1 million in 2022. The result is at the level of the revised guidance in January 2024 for a result at the level of DKK 244 million, but significantly above the expectations at the start of the year of a result of DKK 130-170 million. 

Return on opening equity before tax and dividend was 18.9 % compared to 9.0 % in 2022.

The Bank recommends to the Annual General Meeting that the dividend payment is DKK 55 per share.

Profit before value adjustments and write-downs amounts to MDKK 218.7, compared to MDKK 153.0 in 2022.

Net interest and fee income increased by TDKK 83,527 compared to 2022, amounting to TDKK 435,012.

For the overall year, value adjustment of securities and currencies resulted in a gain of TDKK 40,058 compared to a loss of TDKK 39,356 in 2022.

Impairment of loans, etc. amounted to TDKK 14,160 in 2023, which is TDKK 9,637 higher than in 2022.

Lending increased by 10.6% or TDKK 459,390 in 2023, to TDKK 4,812,975. At the same time, the Bank's guarantees decreased by TDKK 159,699 to TDKK 1,774,426.

The BANK of Greenland's capital ratio amounted to 26.0 at end of 2023, and the Bank has calculated the individual solvency requirement at 11.1%.
  

Outlook for 2024

Greenland is affected by rising inflation, although not at the same level as in other countries, and even though inflation may rise in 2024, we still expect favourable development in the banking business.

Uncertainty in the capital markets will affect the Bank's value adjustments. We nonetheless expect losses and write-downs to remain at a low level, and derived risks related to inflation, rising interest rates and cyclical uncertainty in 2024 are assessed to be covered by the current level of impairment write-downs.

The Bank's expected profit before tax for the year 2024 is DKK 180-230 million. This expectation corresponds to the advice in the stock exchange announcement of 14 December 2023.

Attachments

02.Årsrapport 2023_UK 02.Årsrapport 2023_UK

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

09:17 Aktier/åbning: Zealand tager gigantisk kurshop på milliardaftale
08:54 Obligationer/åbning: Flad renteudvikling før vigtig inflationsrapport
08:46 Zealands aktiekurs kan stige mere end 30 pct. spår Jefferies
08:43 Zealand Pharma har stor tiltro til kombination mellem kronjuvel og mulig "best in class"-molekyle
08:29 Råvarer: Svagere dollar sender oliepriserne i opadgående retning
08:22 Aktier/tendens: Zealand har udsigt til topplacering i ventet grønt marked
08:17 Zealand Pharma har fundet en partner til Petrelintid: Topchef ser enormt potentiale i overskudsdeling
08:00 Tysk våbenproducent skruer lidt ned for salgsvæksten i år efter rekord i 2024
07:37 Zealand har fået gigantaftale med wauw-effekt i hus mener Nordnet
07:32 Obligationer/tendens: Nye rentestigninger i sigte med fokus på amerikansk inflation
07:22 Zealand Pharma finder schweizisk partner til sin kronjuvel
07:06 Novo får skåret kursmålet hos Jefferies efter skuffende Cagrisema-tal
06:58 EU vil indføre nye afgifter som svar på amerikansk told
06:49 DSV får købsanbefaling hos Jefferies: Ser positivt på strategi og Schenker-opkøb
06:38 Genmab får skåret kursmålet hos Morgan Stanley efter Hexabody-afgørelse
06:37 Asien: Bekymrede investorer forsøger at finde fodfæste
06:35 EU vil lægge told på varer fra USA for 26 mia. euro.
06:34 Ukraine støtter forslag om våbenhvile - USA genoptager militær støtte
06:34 Trump dropper toldfordobling - Ontario suspenderer eksporttold
06:34 Nordea får kursmålet sænket med 5 pct. hos Citi